223 related articles for article (PubMed ID: 32320748)
1. Deep brain stimulation of hypothalamus for narcolepsy-cataplexy in mice.
Rogers AA; Aiani LM; Blanpain LT; Yuxian S; Moore R; Willie JT
Brain Stimul; 2020; 13(5):1305-1316. PubMed ID: 32320748
[TBL] [Abstract][Full Text] [Related]
2. Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice.
Liu M; Blanco-Centurion C; Konadhode R; Begum S; Pelluru D; Gerashchenko D; Sakurai T; Yanagisawa M; van den Pol AN; Shiromani PJ
J Neurosci; 2011 Apr; 31(16):6028-40. PubMed ID: 21508228
[TBL] [Abstract][Full Text] [Related]
3. Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children.
Vassalli A; Dellepiane JM; Emmenegger Y; Jimenez S; Vandi S; Plazzi G; Franken P; Tafti M
Brain; 2013 May; 136(Pt 5):1592-608. PubMed ID: 23616586
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
[TBL] [Abstract][Full Text] [Related]
5. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice.
Blanco-Centurion C; Liu M; Konadhode R; Pelluru D; Shiromani PJ
Sleep; 2013 Jan; 36(1):31-40. PubMed ID: 23288969
[TBL] [Abstract][Full Text] [Related]
6. The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice.
Sun Y; Tisdale R; Park S; Ma SC; Heu J; Haire M; Allocca G; Yamanaka A; Morairty SR; Kilduff TS
Sleep; 2022 Dec; 45(12):. PubMed ID: 35182424
[TBL] [Abstract][Full Text] [Related]
7. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.
Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE
Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672
[TBL] [Abstract][Full Text] [Related]
8. Behavioral state instability in orexin knock-out mice.
Mochizuki T; Crocker A; McCormack S; Yanagisawa M; Sakurai T; Scammell TE
J Neurosci; 2004 Jul; 24(28):6291-300. PubMed ID: 15254084
[TBL] [Abstract][Full Text] [Related]
9. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics.
Black SW; Schwartz MD; Chen TM; Hoener MC; Kilduff TS
Biol Psychiatry; 2017 Nov; 82(9):623-633. PubMed ID: 27919403
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive detection of narcolepsy type I phenotypical features and disease progression by continuous home-cage monitoring of activity in two mouse models: the HCRT-KO and DTA model.
Piilgaard L; Rose L; Justinussen JL; Hviid CG; Lemcke R; Wellendorph P; Kornum BR
Sleep; 2023 Sep; 46(9):. PubMed ID: 37210587
[TBL] [Abstract][Full Text] [Related]
11. Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice.
De La Herrán-Arita AK; Zomosa-Signoret VC; Millán-Aldaco DA; Palomero-Rivero M; Guerra-Crespo M; Drucker-Colín R; Vidaltamayo R
Neuroscience; 2011 Jun; 183():134-43. PubMed ID: 21435382
[TBL] [Abstract][Full Text] [Related]
12. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.
Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS
J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset.
Sato M; Sagawa Y; Hirai N; Sato S; Okuro M; Kumar S; Kanbayashi T; Shimizu T; Sakai N; Nishino S
Exp Neurol; 2014 Nov; 261():744-51. PubMed ID: 25118620
[TBL] [Abstract][Full Text] [Related]
14. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.
Tabuchi S; Tsunematsu T; Black SW; Tominaga M; Maruyama M; Takagi K; Minokoshi Y; Sakurai T; Kilduff TS; Yamanaka A
J Neurosci; 2014 May; 34(19):6495-509. PubMed ID: 24806676
[TBL] [Abstract][Full Text] [Related]
15. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
[TBL] [Abstract][Full Text] [Related]
16. Toward the Mysteries of Sleep.
Yanagisawa M
Keio J Med; 2019; 68(1):27. PubMed ID: 30905886
[TBL] [Abstract][Full Text] [Related]
17. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
[TBL] [Abstract][Full Text] [Related]
18. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.
Black SW; Morairty SR; Chen TM; Leung AK; Wisor JP; Yamanaka A; Kilduff TS
J Neurosci; 2014 May; 34(19):6485-94. PubMed ID: 24806675
[TBL] [Abstract][Full Text] [Related]
19. TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.
Ishikawa T; Hara H; Kawano A; Tohyama K; Kajita Y; Miyanohana Y; Koike T; Kimura H
J Pharmacol Exp Ther; 2023 Jun; 385(3):193-204. PubMed ID: 37001988
[TBL] [Abstract][Full Text] [Related]
20. A consensus definition of cataplexy in mouse models of narcolepsy.
Scammell TE; Willie JT; Guilleminault C; Siegel JM;
Sleep; 2009 Jan; 32(1):111-6. PubMed ID: 19189786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
